13G

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 12, 2015

Accession Number

0001020066-15-000008

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →